Watson Launches Generic Version of Sunovion’s Xopenex HCl

Drug Industry Daily
A A
Watson is launching a generic version of Sunovion Pharmaceuticals’ bronchospasm treatment Xopenex inhalation solution after resolving a legal dispute with the brand-drug maker.

To View This Article:

Login

Subscribe To Drug Industry Daily